Novartis Ruling In India Could Spark Larger Movement Against Patent Trolling

By: Tuesday April 2, 2013 8:30 am

So let’s say you are a leading multinational pharmaceutical company and you have a blockbuster cancer drug. You patent the drug, make tremendous profits, but now the clock is ticking and the patent is set to expire. What do you do?

If you are Novartis and your blockbuster cancer drug is Gleevec you are going to engage in a common practice in the pharmaceutical industry – as well as other intellectual property dependent industries – known as evergreening. A few tweaks here, a few tweaks there, and voila reset the clock. The patent is back in effect and the money can keep rolling in. Why spend money on developing new drugs when you can spend just a fraction of that cost on legal bills defending your tweaked patent?


UCSF Physicians Respond to Rep. Eshoo on Evergreening Loophole in Biologics Bill

By: Wednesday December 16, 2009 3:30 pm

As psychiatrists who provide critical psychological counseling and support for many patients living with HIV/AIDS in San Francisco, Drs. Tsai and Rosenlicht have observed firsthand how “evergreening” by the pharmaceutical industry has adversely affected their patients. They respond here to Rep. Anna Eschoo’s recent comments indicating her continued support for the biologics bill.

Bipartisanship Lives! Eshoo Amendment Embraced by GOP in “Alternative” Health Bill

By: Tuesday November 3, 2009 11:45 am

The Republican’s have just released their “alternative” bill to the Democrats’ health care reform legislation. It is frankly a meaningless, very long press release, filled with some really bad ideas. The Republicans did find basically only one section of the Democrats’ reform bill they really liked. In fact, the Republicans thought it was such a [...]

Sherrod Brown: Biologics Should Not be Subject to an “Endless Monopoly Period”

By: Monday November 2, 2009 6:30 pm

Sen. Sherrod Brown of Ohio has been the leading voice in the Senate on the issue of biologics, the expensive drug treatments made from living organisms, and his advocacy for affordable, generic versions of the potentially life-saving drugs will continue once the Senate health care bill hits the floor. The Senate HELP Committee version of [...]

Waxman to Eshoo: You’ve Got an “Evergreening Problem”

By: Monday November 2, 2009 8:15 am

In her response to my article on her biologics bill, Anna Eshoo vehemently claims it doesn’t allow “evergreening,” which would allow slight tweaks in drug formulas to grant drug companies endless monopolies and keep these lifesaving drugs from ever becoming generics: There is no ‘evergreening’ clause in my legislation. There is in fact an ‘anti-evergreening’ [...]

Follow Firedoglake
CSM Ads advertisement